MBrace Therapeutics

Translating Innovative ADC Discovery into Transformative Therapies for Cancer Patients

San Diego, United States · $114.0M raised

Business Model
B2B
Total Funding
$114.0M
Last Round
$4.0M SeedNov 2023
Rounds
3

About

MBrace Therapeutics translates innovative antibody-drug conjugate discovery into transformative therapies for cancer patients. The company uses an integrative drug-development approach that combines researchers, physicians, and its development team to advance novel oncology treatments. Its clinical programs include ADC candidates MBRC-101 and MBRC-201. Each member of the team has been impacted by cancer, and that experience underpins a commitment to translate research into new treatment options for patients.

Summary

MBrace Therapeutics is a Biotech company based in San Diego, United States. It has raised $114.0M in total across 3 rounds, most recently a $4.0M Seed round in Nov 2023. Investors include Venrock, TPG Life Sciences Innovation and Advanced Technology Ventures.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series BSeries BNov 2023
$85.0M

Sign up to see all 3 rounds

Seed through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

MBrace Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/mbrace-therapeutics"><img src="https://indexed.vc/api/badge/company/mbrace-therapeutics" alt="MBrace Therapeutics on Indexed.vc" width="260" height="76" /></a>